1 - 2 of 2
1
Journal article icon

Journal article

Characterization of CCX282-B, an orally bioavailable antagonist of the CCR9 chemokine receptor, for treatment of inflammatory bowel disease.

  • Walters, M, Wang, Y, Lai, N, et al.
  • 2010-10-01
2
Journal article icon

Journal article

Pharmacological inhibition of CCR9 is a novel approach in the treatment of inflammatory bowel disease

  • Bekker, P, Keshav, S, Wei, Z, et al.
  • 2007-06-01
FILTER RESULTS

TO TOP